Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-21-006595
Filing Date
2021-09-23
Accepted
2021-09-23 16:44:03
Documents
1
Period of Report
2021-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 10858
  Complete submission text file 0001477932-21-006595.txt   12384
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Issuer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 13215 BEE CAVE PARKWAY SUITE 125 GALLERIA OAKS B AUSTIN TX 78738
Business Address
Micallef Jacob Vincent (Reporting) CIK: 0001651671 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36833 | Film No.: 211272990